Weld Capital Management’s Editas Medicine EDIT Stock Holding History

Weld Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,445	Closed	-$349K	–	522
2020 Q3	$349K	Buy	12,445 +3,329	+37%	+$108K	0.14%	254
2020 Q2	$270K	Buy	+9,116	New	+$238K	0.11%	308
2019 Q3	–	Sell	-33,810	Closed	-$836K	–	817
2019 Q2	$836K	Buy	+33,810	New	+$807K	0.15%	230

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Weld Capital Management's EDIT Position: Q4 2020 in Review

Weld Capital Management sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 12,445 shares — an estimated $349K sold.

Weld Capital Management first reported a position in EDIT in Q2 2019 and held it in 3 quarters. The position peaked at $836K in Q2 2019. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

Weld Capital Management reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
Weld Capital Management sold 12,445 Editas Medicine shares in Q4 2020, an estimated $349K.
Weld Capital Management first reported a position in Editas Medicine in Q2 2019 and held it in 3 quarters.
Weld Capital Management's Editas Medicine position peaked at $836K in Q2 2019.
311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Weld Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.